A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
NCT ID: NCT00002084
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Valacyclovir hydrochloride
Acyclovir
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV infection with CD4 counts = or \> 100 cells/mm3.
* Documented culture of anogenital herpes simplex virus (HSV) within the last 5 years.
* History of recurrent anogenital HSV infection, with a recurrence (with or without culture) within 1 year prior to study.
Exclusion Criteria
Patients with the following symptoms and conditions are excluded:
* Malabsorption or vomiting that would potentially limit the retention and absorption of oral therapy.
Concurrent Medication:
Excluded:
* Systemic antiherpes medication.
* Interferon.
Patients with the following prior conditions are excluded:
History of hypersensitivity to acyclovir.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glaxo Wellcome
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univ of South Alabama
Mobile, Alabama, United States
Univ of Arizona / Health Science Ctr
Tucson, Arizona, United States
Combat Group
Los Angeles, California, United States
Los Angeles County - USC Med Ctr
Los Angeles, California, United States
Infectious Disease Med Group / Adult Immunology Clinic
Oakland, California, United States
UCI Med Ctr
Orange, California, United States
UCSD Med Ctr
San Diego, California, United States
San Diego Naval Hosp
San Diego, California, United States
ViRx Inc
San Francisco, California, United States
UCSF - San Francisco Gen Hosp
San Francisco, California, United States
Dr Marcus Conant
San Francisco, California, United States
West Haven Veterans Administration Med Ctr
West Haven, Connecticut, United States
Georgetown Univ Med Ctr
Washington D.C., District of Columbia, United States
Whitman - Walker Clinic
Washington D.C., District of Columbia, United States
George Washington Univ Med Ctr
Washington D.C., District of Columbia, United States
Veterans Administration Med Ctr / Regional AIDS Program
Washington D.C., District of Columbia, United States
Univ of South Florida
St. Petersburg, Florida, United States
Emory Univ School of Medicine
Atlanta, Georgia, United States
AIDS Research Consortium of Atlanta
Atlanta, Georgia, United States
Northwestern Memorial Hosp
Chicago, Illinois, United States
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois, United States
Infectious Diseases Research Clinic / Indiana Univ Hosp
Indianapolis, Indiana, United States
Univ of Iowa Hosp & Clinic
Iowa City, Iowa, United States
Univ of Kansas School of Medicine
Wichita, Kansas, United States
Univ of Maryland at Baltimore
Baltimore, Maryland, United States
St Paul Ramsey Med Ctr
Saint Paul, Minnesota, United States
Univ of Mississippi Med Ctr
Jackson, Mississippi, United States
Univ of Missouri at Kansas City School of Medicine
Kansas City, Missouri, United States
St Louis Univ
St Louis, Missouri, United States
Beth Israel Med Ctr
New York, New York, United States
Saint Vincent's Hosp and Med Ctr
New York, New York, United States
Mount Sinai Med Ctr
New York, New York, United States
Univ of Rochester Med Ctr
Rochester, New York, United States
Portland Veterans Adm Med Ctr / Rsch & Education Grp
Portland, Oregon, United States
Buckley Braffman Stern Med Associates
Philadelphia, Pennsylvania, United States
Univ of Pittsburgh / Graduate School of Public Health
Pittsburgh, Pennsylvania, United States
Roger Williams Med Ctr
Providence, Rhode Island, United States
Regional Med Ctr at Memphis
Memphis, Tennessee, United States
Dallas Associated Dermatologists
Dallas, Texas, United States
Univ TX Galveston Med Branch
Galveston, Texas, United States
Thomas Audetta Clinic
Houston, Texas, United States
Baylor College of Medicine / Texas Med Ctr
Houston, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
MacGregor Med Association
Houston, Texas, United States
Univ TX Med Branch / Ctr for Clinical Studies
Nassau Bay, Texas, United States
Med College of Virginia
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07
Identifier Type: -
Identifier Source: secondary_id
104B
Identifier Type: -
Identifier Source: org_study_id